New Open MRI System from Fujifilm Combines Technology Advances with Patient Comfort
The Aperto Lucent open 0.4T MRI platform reportedly offers enhanced fat suppression and spatial resolution capabilities in addition to its open architecture design.
Emphasizing patient comfort, workflow efficiencies and enhanced imaging quality, Fujifilm has launched the Aperto Lucent open 0.4T magnetic resonance imaging (MRI) system.
The system’s wide laterally moving table and single-pillar design are key factors in promoting patient comfort, according to Fujifilm.
In addition to the platform’s permanent magnet technology, the company said the Aperto Lucent provides an array of features to facilitate efficient quality imaging.
In addition to promoting patient comfort, the Aperto Lucent open 0.4T MRI system reportedly provides enhanced fat suppression capabilities and improved spatial resolution. (Image courtesy of Fujifilm.)
• Fat suppression features include eight channels of active patient shimming and chemical shift-selective (CHESS) type radiofrequency (RF) fat saturation, which complements short tau inversion recovery (STIR) sequences.
• A combination of solenoid technology RF receiver coils and the IP-Recon iterative image reconstruction algorithm facilitate a high signal-to-noise ratio (SNR) and enhanced spatial resolution, according to Fujifilm.
• In order to address challenges with patient motion, Fujifilm said the Aperto Lucent system has RADAR motion compensating pulse sequence technology that reduces artifacts and the potential for rescans.
“APERTO Lucent is a perfect solution for providers looking for a space-saving, cost-effective system that enhances the MRI patient experience,” noted Shawn Etheridge, the executive director of modality solutions marketing for Fujifilm Healthcare Americas Corporation. “With permanent magnet open MRI technology, there is little need for additional equipment and infrastructure to maintain the magnetic field, keeping installation and operating costs low for our customers and providing a stronger return on investment.”
Could Ultrafast MRI Enhance Detection of Malignant Foci for Breast Cancer?
April 10th 2025In a new study involving over 120 women, nearly two-thirds of whom had a family history of breast cancer, ultrafast MRI findings revealed a 5 percent increase in malignancy risk for each second increase in the difference between lesion and background parenchymal enhancement (BPE) time to enhancement (TTE).
MRI Study Suggests Shape of White Matter Hyperintensities May Be Predictive of Cognitive Decline
April 7th 2025Emerging research demonstrated that cognitive declines in memory, executive function and processing speed domains were associated with irregular shape of periventricular/confluent white matter hyperintensities.
Can Abbreviated MRI Have an Impact in Rectal Cancer Staging?
April 4th 2025Abbreviated MRI demonstrated a 95.3 percent specificity for rectal cancer and provided strong agreement with the full MRI protocol for T staging and detection of extramural venous invasion, according to newly published research.
